FI955587A7 - Kemialliset yhdisteet - Google Patents

Kemialliset yhdisteet Download PDF

Info

Publication number
FI955587A7
FI955587A7 FI955587A FI955587A FI955587A7 FI 955587 A7 FI955587 A7 FI 955587A7 FI 955587 A FI955587 A FI 955587A FI 955587 A FI955587 A FI 955587A FI 955587 A7 FI955587 A7 FI 955587A7
Authority
FI
Finland
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Application number
FI955587A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI955587A0 (fi
Inventor
Peter Clive Cherry
John Derek Cocker
Andrew David Searle
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI955587A0 publication Critical patent/FI955587A0/fi
Publication of FI955587A7 publication Critical patent/FI955587A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI955587A 1993-05-21 1995-11-20 Kemialliset yhdisteet FI955587A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939310635A GB9310635D0 (en) 1993-05-21 1993-05-21 Chemical compounds
PCT/EP1994/001613 WO1994027989A1 (en) 1993-05-21 1994-05-19 Carbazole derivatives with 17,20-lyase-inhibiting activity

Publications (2)

Publication Number Publication Date
FI955587A0 FI955587A0 (fi) 1995-11-20
FI955587A7 true FI955587A7 (fi) 1995-11-20

Family

ID=10736007

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955587A FI955587A7 (fi) 1993-05-21 1995-11-20 Kemialliset yhdisteet

Country Status (19)

Country Link
EP (1) EP0699196A1 (cg-RX-API-DMAC10.html)
JP (1) JPH08510455A (cg-RX-API-DMAC10.html)
CN (1) CN1126473A (cg-RX-API-DMAC10.html)
AU (1) AU6928794A (cg-RX-API-DMAC10.html)
BG (1) BG100154A (cg-RX-API-DMAC10.html)
CA (1) CA2162921A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ305195A3 (cg-RX-API-DMAC10.html)
FI (1) FI955587A7 (cg-RX-API-DMAC10.html)
GB (1) GB9310635D0 (cg-RX-API-DMAC10.html)
HU (1) HUT73790A (cg-RX-API-DMAC10.html)
IL (1) IL109703A0 (cg-RX-API-DMAC10.html)
NO (1) NO954681D0 (cg-RX-API-DMAC10.html)
OA (1) OA10195A (cg-RX-API-DMAC10.html)
PE (1) PE31195A1 (cg-RX-API-DMAC10.html)
PL (1) PL311702A1 (cg-RX-API-DMAC10.html)
SK (1) SK142495A3 (cg-RX-API-DMAC10.html)
TW (1) TW279866B (cg-RX-API-DMAC10.html)
WO (1) WO1994027989A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA943494B (cg-RX-API-DMAC10.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960704852A (ko) * 1993-09-30 1996-10-09 오노다 마사요시 아졸 유도체 및 이의 약제학적 조성물 (Azole derivative and pharmaceutical composition thereof)
WO1996014090A1 (en) * 1994-11-07 1996-05-17 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
AU702406B2 (en) * 1995-03-01 1999-02-18 Yamanouchi Pharmaceutical Co., Ltd. Imidazole derivatives and medicinal composition thereof
CA2281598A1 (en) * 1997-02-21 1998-08-27 Tetsuya Aono Fused ring compounds, process for producing the same and use thereof
MXPA03004347A (es) 2000-11-17 2004-05-04 Takeda Chemical Industries Ltd Nuevos derivados de imidazol, metodo de produccion y uso de los mismos.
US6960586B2 (en) 2000-11-20 2005-11-01 Takeda Pharmaceutical Company Limited Imidazole derivatives, process for their preparation and their use
EP1348706B1 (en) 2000-12-08 2009-08-19 Takeda Pharmaceutical Company Limited Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
DK1902026T3 (da) 2005-06-24 2010-04-26 Lilly Co Eli Tetrahydrocarbazol-derivater, der kan anvendes som androgen-receptor-modulatorer (SARM)
US8093279B2 (en) 2005-12-13 2012-01-10 Gillian Reed, legal representative Compound
GB0525323D0 (en) * 2005-12-13 2006-01-18 Sterix Ltd Compound
CN100586932C (zh) * 2007-01-26 2010-02-03 中国医学科学院医药生物技术研究所 抗肿瘤化合物及其制备方法
KR101360725B1 (ko) 2009-06-26 2014-02-07 노파르티스 아게 Cyp17의 억제제로서의 1,3-이치환된 이미다졸리딘-2-온 유도체
AU2011212813B2 (en) 2010-02-04 2014-10-23 Radius Health, Inc. Selective androgen receptor modulators
CA2799183A1 (en) 2010-05-12 2011-11-17 Radius Health, Inc. Therapeutic regimens
US9132105B2 (en) 2010-08-04 2015-09-15 Pellficure Pharmaceuticals, Inc. Treatment of prostate carcinoma
US8946260B2 (en) 2010-09-16 2015-02-03 Novartis Ag 17α-hydroxylase/C17,20-lyase inhibitors
US9133182B2 (en) 2010-09-28 2015-09-15 Radius Health, Inc. Selective androgen receptor modulators
WO2012149413A1 (en) 2011-04-28 2012-11-01 Novartis Ag 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS
US9492460B2 (en) * 2013-02-27 2016-11-15 Bristol-Myers Squibb Company Carbazole compounds useful as bromodomain inhibitors
US20160022606A1 (en) 2013-03-14 2016-01-28 Pellficure Pharmaceuticals Inc. Novel therapy for prostate carcinoma
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
HRP20251500T1 (hr) 2014-03-28 2026-01-02 Duke University Liječenje raka dojke pozitivnog na receptor estrogena uporabom selektivnih modulatora receptora estrogena
US10093620B2 (en) 2014-09-12 2018-10-09 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
ES2913470T3 (es) 2016-06-22 2022-06-02 Ellipses Pharma Ltd Métodos de tratamiento de cáncer de mama AR+
CA3044812A1 (en) 2016-10-24 2018-05-03 Pellficure Pharmaceuticals Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dione
AU2018205285C9 (en) 2017-01-05 2024-05-23 Radius Pharmaceuticals, Inc. Polymorphic forms of RAD1901-2HCl

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
PL311702A1 (en) 1996-03-04
FI955587A0 (fi) 1995-11-20
TW279866B (cg-RX-API-DMAC10.html) 1996-07-01
PE31195A1 (es) 1995-10-18
CA2162921A1 (en) 1994-12-08
AU6928794A (en) 1994-12-20
ZA943494B (en) 1995-01-23
SK142495A3 (en) 1996-06-05
NO954681L (no) 1995-11-20
WO1994027989A1 (en) 1994-12-08
CZ305195A3 (en) 1996-06-12
IL109703A0 (en) 1994-08-26
HUT73790A (en) 1996-09-30
OA10195A (en) 1996-12-18
GB9310635D0 (en) 1993-07-07
JPH08510455A (ja) 1996-11-05
NO954681D0 (no) 1995-11-20
HU9503321D0 (en) 1996-01-29
CN1126473A (zh) 1996-07-10
EP0699196A1 (en) 1996-03-06
BG100154A (en) 1996-07-31

Similar Documents

Publication Publication Date Title
FI954327L (fi) Atsasykloheksapeptidiyhdisteitä
FI922424A7 (fi) Kemiallisia yhdisteitä
FI955587A7 (fi) Kemialliset yhdisteet
FI944078A7 (fi) Kemiallisia yhdisteitä
FI961696L (fi) Pyridatsinokinoliiniyhdisteitä
MX9101375A (es) Compuestos quimicos
BR1101108A (pt) Composto
FI941574L (fi) Kemiallisia yhdisteitä
FI972683L (fi) Kemiallisia yhdisteitä
FI911286A7 (fi) Kemialliset yhdisteet
FI954016A7 (fi) Uudet yhdisteet
DK72693D0 (da) Compounds
FI922423A7 (fi) Kemiallisia yhdisteitä
FI945907A7 (fi) Kemiallisia yhdisteitä
DK124393D0 (da) Compounds
DE59409946D1 (de) Antidröhnmassen.
FI954017A7 (fi) Uudet yhdisteet
NO962264D0 (no) Kjemiske forbindelser
MX9205851A (es) Compuestos quimicos
FI954399L (fi) Kemiallinen prosessi
DK244090D0 (da) Kemiske forbindelser
ITRM940566A0 (it) Composti organici
FI954400L (fi) Kemiallinen prosessi
DK150591D0 (da) Kemisk forbindelse
FI943637L (fi) Aryylialkoksifenoksi-imidatsoliiniyhdisteitä

Legal Events

Date Code Title Description
FD Application lapsed